Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5194 publications
Comparative efficacy and safety of biosimilar Bmab 1200 versus reference ustekinumab in moderate-to-severe plaque psoriasis: 52-week findings from the Phase 3 STELLAR-2 trial.
Journal: Expert opinion on biological therapy
Published: October 16, 2025
Predictive factors for early super response to bimekizumab in 341 patients with psoriasis-a 24-week short-term multicenter real-life experience.
Journal: The Journal of dermatological treatment
Published: October 01, 2025
Clinical efficacy, drug retention and recurrence of ixekizumab across psoriasis severities: a multicenter retrospective analysis of 354 patients.
Journal: The Journal of dermatological treatment
Published: October 01, 2025
A real world study on the effectiveness and safety of deu-cravacitinib in the treatment of moderate to severe plaque psoriasis in China
Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Published: September 30, 2025
Efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis across different regions of China: a post-hoc exploratory analysis of a phase III, randomized controlled trial.
Journal: The Journal of dermatological treatment
Published: September 29, 2025
Early response to vunakizumab and its baseline predictors in patients with moderate-to-severe plaque psoriasis: a post hoc analysis of a phase-III trial.
Journal: The Journal of dermatological treatment
Published: September 25, 2025
Comparative Efficacy of Traditional Unani Medicine Formulations Versus Apremilast for Chronic Plaque Psoriasis: A Randomized Controlled Trial.
Journal: Alternative therapies in health and medicine
Published: September 23, 2025
Safety, pharmacokinetics, and bioequivalence of vunakizumab injection, a specific dermatitis drug, in healthy Chinese volunteers: an open-label, randomized, two-stage, two-sequence cross-over study.
Journal: Expert opinion on drug metabolism & toxicology
Published: September 14, 2025
Evaluation of Short-to-medium Term Efficacy of Guselkumab and Secukinumab in Overweight and Obese Patients with Moderate to Severe Plaque Psoriasis: A 24-Week Single-center Retrospective Study.
Journal: Indian journal of dermatology
Published: September 08, 2025
Pre-Treatment Nutritional Status as a Predictor of Clinical Outcomes in Moderate-to-Severe Plaque Psoriasis Patients Undergoing Cyclosporine A Therapy.
Journal: Nutrients
Published: September 02, 2025
Correction: Biologics for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Network Meta-analysis.
Journal: Dermatology and therapy
Published: August 25, 2025
Efficacy and tolerability of bimekizumab within patients with moderate-to-severe plaque psoriasis: learnings from real world evidence.
Journal: Expert opinion on drug safety
Published: August 23, 2025
Last Updated: 10/31/2025